• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心力衰竭患者的公共援助:来自 KCHF 登记处的报告。

Public assistance in patients with acute heart failure: a report from the KCHF registry.

机构信息

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

出版信息

ESC Heart Fail. 2022 Jun;9(3):1920-1930. doi: 10.1002/ehf2.13898. Epub 2022 Mar 15.

DOI:10.1002/ehf2.13898
PMID:35289117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9065832/
Abstract

AIMS

There is a scarcity of data on the post-discharge prognosis in acute heart failure (AHF) patients with a low-income but receiving public assistance. The study sought to evaluate the differences in the clinical characteristics and outcomes between AHF patients receiving public assistance and those not receiving public assistance.

METHODS AND RESULTS

The Kyoto Congestive Heart Failure registry was a physician-initiated, prospective, observational, multicentre cohort study enrolling 4056 consecutive patients who were hospitalized due to AHF for the first time between October 2014 and March 2016. The present study population consisted of 3728 patients who were discharged alive from the index AHF hospitalization. We divided the patients into two groups, those receiving public assistance and those not receiving public assistance. After assessing the proportional hazard assumption of public assistance as a variable, we constructed multivariable Cox proportional hazard models to estimate the risk of the public assistance group relative to the no public assistance group. There were 218 patients (5.8%) receiving public assistance and 3510 (94%) not receiving public assistance. Patients in the public assistance group were younger, more frequently had chronic coronary artery disease, previous heart failure hospitalizations, current smoking, poor medical adherence, living alone, no occupation, and a lower left ventricular ejection fraction than those in the no public assistance group. During a median follow-up of 470 days, the cumulative 1 year incidences of all-cause death and heart failure hospitalizations after discharge did not differ between the public assistance group and no public assistance group (13.3% vs. 17.4%, P = 0.10, and 28.3% vs. 23.8%, P = 0.25, respectively). After adjusting for the confounders, the risk of the public assistance group relative to the no public assistance group remained insignificant for all-cause death [hazard ratio (HR), 0.97; 95% confidence interval (CI), 0.69-1.32; P = 0.84]. Even after taking into account the competing risk of all-cause death, the adjusted risk within 180 days in the public assistance group relative to the no public assistance group remained insignificant for heart failure hospitalizations (HR, 0.93; 95% CI, 0.64-1.34; P = 0.69), while the adjusted risk beyond 180 days was significant (HR, 1.56; 95% CI, 1.07-2.29; P = 0.02).

CONCLUSIONS

The AHF patients receiving public assistance as compared with those not receiving public assistance had no significant excess risk for all-cause death at 1 year after discharge or a heart failure hospitalization within 180 days after discharge, while they did have a significant excess risk for heart failure hospitalizations beyond 180 days after discharge.

CLINICAL TRIAL REGISTRATION

https://clinicaltrials.gov/ct2/show/NCT02334891 (NCT02334891) and https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017241 (UMIN000015238).

摘要

目的

在接受公共援助的低收入急性心力衰竭(AHF)患者中,关于出院后预后的数据稀缺。本研究旨在评估接受公共援助和未接受公共援助的 AHF 患者之间的临床特征和结局差异。

方法和结果

京都充血性心力衰竭注册研究是一项由医师发起的前瞻性观察性多中心队列研究,纳入了 2014 年 10 月至 2016 年 3 月期间首次因 AHF 住院的 4056 例连续患者。本研究人群包括 3728 例从指数 AHF 住院中存活出院的患者。我们将患者分为两组,一组接受公共援助,另一组未接受公共援助。在评估公共援助作为变量的比例风险假设后,我们构建了多变量 Cox 比例风险模型来估计公共援助组相对于无公共援助组的风险。有 218 例(5.8%)患者接受公共援助,3510 例(94%)未接受公共援助。与无公共援助组相比,公共援助组患者更年轻,更频繁地患有慢性冠状动脉疾病、既往心力衰竭住院、当前吸烟、药物依从性差、独居、无职业和左心室射血分数较低。在中位数为 470 天的随访期间,出院后全因死亡和心力衰竭住院的 1 年累积发生率在公共援助组和无公共援助组之间没有差异(13.3%对 17.4%,P=0.10;28.3%对 23.8%,P=0.25)。在校正混杂因素后,公共援助组相对于无公共援助组的全因死亡风险仍无显著差异[风险比(HR),0.97;95%置信区间(CI),0.69-1.32;P=0.84]。即使考虑到全因死亡的竞争风险,公共援助组在 180 天内相对于无公共援助组的心衰住院风险也无显著差异(HR,0.93;95%CI,0.64-1.34;P=0.69),而超过 180 天后的调整风险显著(HR,1.56;95%CI,1.07-2.29;P=0.02)。

结论

与未接受公共援助的患者相比,接受公共援助的 AHF 患者出院后 1 年全因死亡或出院后 180 天内心力衰竭住院的风险无显著增加,但出院后 180 天以上心力衰竭住院的风险显著增加。

临床试验注册

https://clinicaltrials.gov/ct2/show/NCT02334891(NCT02334891)和 https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017241(UMIN000015238)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d830/9065832/1a1608a2cfe5/EHF2-9-1920-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d830/9065832/4e860e10307c/EHF2-9-1920-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d830/9065832/a019ce52ad5c/EHF2-9-1920-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d830/9065832/1a1608a2cfe5/EHF2-9-1920-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d830/9065832/4e860e10307c/EHF2-9-1920-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d830/9065832/a019ce52ad5c/EHF2-9-1920-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d830/9065832/1a1608a2cfe5/EHF2-9-1920-g003.jpg

相似文献

1
Public assistance in patients with acute heart failure: a report from the KCHF registry.急性心力衰竭患者的公共援助:来自 KCHF 登记处的报告。
ESC Heart Fail. 2022 Jun;9(3):1920-1930. doi: 10.1002/ehf2.13898. Epub 2022 Mar 15.
2
C-reactive protein at discharge and 1-year mortality in hospitalised patients with acute decompensated heart failure: an observational study.出院时 C 反应蛋白与急性失代偿性心力衰竭住院患者 1 年死亡率:一项观察性研究。
BMJ Open. 2020 Dec 29;10(12):e041068. doi: 10.1136/bmjopen-2020-041068.
3
Prognostic Value of the Severity of Clinical Congestion in Patients Hospitalized for Decompensated Heart Failure: Findings From the Japanese KCHF Registry.因失代偿性心力衰竭住院患者临床充血严重程度的预后价值:来自日本 KCHF 登记处的结果。
J Card Fail. 2023 Aug;29(8):1150-1162. doi: 10.1016/j.cardfail.2023.01.003. Epub 2023 Jan 21.
4
The characteristics and outcomes in patients with acute heart failure who used tolvaptan: from KCHF registry.使用托伐普坦的急性心力衰竭患者的特征及结局:来自韩国充血性心力衰竭注册研究
ESC Heart Fail. 2023 Oct;10(5):3141-3151. doi: 10.1002/ehf2.14494. Epub 2023 Aug 29.
5
Risk Factors and Clinical Outcomes of Nonhome Discharge in Patients With Acute Decompensated Heart Failure: An Observational Study.急性失代偿性心力衰竭患者非家庭出院的风险因素和临床结局:一项观察性研究。
J Am Heart Assoc. 2021 Aug 3;10(15):e020292. doi: 10.1161/JAHA.120.020292. Epub 2021 Jul 30.
6
Tricuspid regurgitation in elderly patients with acute heart failure: insights from the KCHF registry.老年急性心力衰竭患者的三尖瓣反流:来自 KCHF 注册研究的见解。
ESC Heart Fail. 2023 Jun;10(3):1948-1960. doi: 10.1002/ehf2.14348. Epub 2023 Mar 29.
7
Insomnia in patients with acute heart failure: from the KCHF registry.急性心力衰竭患者的失眠:来自 KCHF 登记研究。
ESC Heart Fail. 2022 Oct;9(5):2988-2996. doi: 10.1002/ehf2.14025. Epub 2022 Jun 22.
8
Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry.急性心力衰竭住院诱发因素的区域性差异:来自 REPORT-HF 注册研究的启示。
Eur J Heart Fail. 2022 Apr;24(4):645-652. doi: 10.1002/ejhf.2431. Epub 2022 Feb 17.
9
Prognostic Importance of Right Ventricular-Vascular Uncoupling in Acute Decompensated Heart Failure With Preserved Ejection Fraction.右心室-血管解偶联对射血分数保留的急性失代偿性心力衰竭的预后意义。
Circ Cardiovasc Imaging. 2020 Nov;13(11):e011430. doi: 10.1161/CIRCIMAGING.120.011430. Epub 2020 Nov 17.
10
Newly Diagnosed Infection After Admission for Acute Heart Failure: From the KCHF Registry.新诊断的急性心力衰竭入院后感染:来自 KCHF 登记处。
J Am Heart Assoc. 2021 Nov 16;10(22):e023256. doi: 10.1161/JAHA.121.023256. Epub 2021 Nov 3.

引用本文的文献

1
Effectiveness of an Impella Versus Intra-Aortic Balloon Pump in Patients Who Received Extracorporeal Membrane Oxygenation.接受体外膜肺氧合治疗的患者中,Impella与主动脉内球囊反搏的疗效比较
J Am Heart Assoc. 2025 Feb 4;14(3):e037652. doi: 10.1161/JAHA.124.037652. Epub 2025 Feb 3.
2
Recipients of public assistance with advanced chronic kidney disease: insights into receiving a presentation of kidney replacement therapy options and polypharmacy from Japanese investigators with innovative network about kidney disease study.晚期慢性肾病公共援助接受者:来自日本具有创新肾病研究网络的研究者关于肾脏替代治疗选择及多种药物治疗的介绍见解
Clin Exp Nephrol. 2025 Jan;29(1):67-74. doi: 10.1007/s10157-024-02549-9. Epub 2024 Aug 22.
3

本文引用的文献

1
Association between the health insurance status and clinical outcomes among patients with acute heart failure in Japan.日本急性心力衰竭患者的健康保险状况与临床结局之间的关联。
Heart Vessels. 2022 Jan;37(1):83-90. doi: 10.1007/s00380-021-01895-y. Epub 2021 Jun 22.
2
Association of Previous Hospitalization for Heart Failure With Increased Mortality in Patients Hospitalized for Acute Decompensated Heart Failure.既往因心力衰竭住院与急性失代偿性心力衰竭住院患者死亡率增加的关联。
Circ Rep. 2019 Oct 26;1(11):517-524. doi: 10.1253/circrep.CR-19-0054.
3
Income level and outcomes in patients with heart failure with universal health coverage.
Health Statuses of People in Poverty Receiving Public Assistance in Japan: A Scoping Review.
日本接受公共援助的贫困人口的健康状况:一项范围综述。
JMA J. 2024 Jul 16;7(3):301-312. doi: 10.31662/jmaj.2024-0062. Epub 2024 Jun 28.
全民健康覆盖下心力衰竭患者的收入水平和结局。
Heart. 2021 Feb;107(3):208-216. doi: 10.1136/heartjnl-2020-316793. Epub 2020 Oct 20.
4
Socioeconomic Gradients in Mortality Following HF Hospitalization in a Country With Universal Health Care Coverage.在全民医保覆盖的国家,心力衰竭住院后死亡率的社会经济梯度。
JACC Heart Fail. 2020 Nov;8(11):917-927. doi: 10.1016/j.jchf.2020.05.015. Epub 2020 Oct 7.
5
Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.射血分数保留、中间范围和降低的心衰日本成年人的死亡模式。
JAMA Netw Open. 2020 May 1;3(5):e204296. doi: 10.1001/jamanetworkopen.2020.4296.
6
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.按世界地区、收入水平和收入差距划分的因心力衰竭住院患者出院后的预后(REPORT-HF):一项队列研究。
Lancet Glob Health. 2020 Mar;8(3):e411-e422. doi: 10.1016/S2214-109X(20)30004-8.
7
Risk factors and clinical outcomes of functional decline during hospitalisation in very old patients with acute decompensated heart failure: an observational study.高龄急性失代偿性心力衰竭患者住院期间功能下降的危险因素和临床转归:一项观察性研究。
BMJ Open. 2020 Feb 16;10(2):e032674. doi: 10.1136/bmjopen-2019-032674.
8
Socioeconomic Factors and Clinical Outcomes Among Patients With Heart Failure in a Universal Health Care System.在全民医保体系中,心力衰竭患者的社会经济因素与临床结局。
JACC Heart Fail. 2019 Sep;7(9):746-755. doi: 10.1016/j.jchf.2019.06.003.
9
Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure.螺内酯类药物受体拮抗剂的使用与老年急性失代偿性心力衰竭患者全因死亡率和再入院率的关系。
JAMA Netw Open. 2019 Jun 5;2(6):e195892. doi: 10.1001/jamanetworkopen.2019.5892.
10
Demographics, Management, and In-Hospital Outcome of Hospitalized Acute Heart Failure Syndrome Patients in Contemporary Real Clinical Practice in Japan - Observations From the Prospective, Multicenter Kyoto Congestive Heart Failure (KCHF) Registry.日本当代真实临床实践中住院急性心力衰竭综合征患者的人口统计学、管理和住院期间结局 - 来自前瞻性、多中心京都充血性心力衰竭(KCHF)注册研究的观察。
Circ J. 2018 Oct 25;82(11):2811-2819. doi: 10.1253/circj.CJ-17-1386. Epub 2018 Sep 26.